Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy G Richman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|November 6, 2008
Nicotinic acid receptor agonistsP Douglas Boatman, Jeremy G Richman, Graeme Semple
Current Opinion in Drug Discovery & Development|July 31, 2007
Recent progress in the discovery of niacin receptor agonistsGraeme Semple, P Douglas Boatman, Jeremy G Richman
The Journal of Investigative Dermatology|September 30, 2006
Langerhans cells release prostaglandin D2 in response to nicotinic acidDominique Maciejewski-Lenoir, Jeremy G Richman, Yaron Hakak, et al.
Life Sciences|January 22, 2003
Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytesAmy C Porter, Samuel P S Svensson, W Daniel Stamer, et al.
Journal of Medicinal Chemistry|February 17, 2006
1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109bGraeme Semple, Philip J Skinner, Martin C Cherrier, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2009
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109bPhilip J Skinner, Peter J Webb, Carleton R Sage, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 29, 2025
Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosingSteven M Weldon, Derek A Cogan, Matthew A Cerny, et al.
Journal of Medicinal Chemistry|March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109bJae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|November 6, 2008
Nicotinic acid receptor agonistsP Douglas Boatman, Jeremy G Richman, Graeme Semple
Current Opinion in Drug Discovery & Development|July 31, 2007
Recent progress in the discovery of niacin receptor agonistsGraeme Semple, P Douglas Boatman, Jeremy G Richman
The Journal of Investigative Dermatology|September 30, 2006
Langerhans cells release prostaglandin D2 in response to nicotinic acidDominique Maciejewski-Lenoir, Jeremy G Richman, Yaron Hakak, et al.
Life Sciences|January 22, 2003
Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytesAmy C Porter, Samuel P S Svensson, W Daniel Stamer, et al.
Journal of Medicinal Chemistry|February 17, 2006
1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109bGraeme Semple, Philip J Skinner, Martin C Cherrier, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2009
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109bPhilip J Skinner, Peter J Webb, Carleton R Sage, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 29, 2025
Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosingSteven M Weldon, Derek A Cogan, Matthew A Cerny, et al.
Journal of Medicinal Chemistry|March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109bJae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
European Journal of Pharmacology|March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonistJohn W Adams, Juan Ramirez, Danny Ortuno, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109bPhilip J Skinner, Martin C Cherrier, Peter J Webb, et al.
Pageof 2